-transparent.png){kind=logo}
The effects of orally administered dilazep, an antianginal drug, on the hemoglobin-oxygen affinity were studied in 31 cases with ischemic heart disease. Prior to medication, the mean P50 value was 29.2 +/- 1.65 mmHg. There were no significant differences in the P50 value according to the age of patient or the severity of the coronary arterial disease. Acute effects of dilazep were studied in 29 patients. The 30 min and 60 min post-administration P50 values increased significantly to 30.2 +/- 2.55 mmHg and 30.4 +/- 2.31 mmHg, respectively. Eight patients were administered 300 mg of oral dilazep daily for 4 weeks. Three of 4 in whom exercise tolerance improved showed increases in P50. No changes in various factors which might affect the P50 value, including 2,3-DPG, were found.
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
January 1977,
Advances in experimental medicine and biology,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
September 1998,
American journal of hematology,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
January 1985,
The American review of respiratory disease,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
December 1971,
American heart journal,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
January 1974,
Critical care medicine,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
January 1988,
Padiatrie und Grenzgebiete,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
October 1977,
The Journal of pharmacology and experimental therapeutics,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
March 1980,
The Journal of surgical research,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
March 1972,
Blood,
M Koshu, and
T Sugimoto, and
Y Terada, and
T Uraoka
March 2006,
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
